PT Kalbe Farma Tbk, or simply known as Kalbe, is an Indonesian pharmaceutical, healthcare and nutrition company established in 1966.[citation needed] The company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise. The Kalbe Group has brands in the prescription drugs, OTC drugs, energy drink and nutrition products, distribution arm that reaches over 1 million outlets. Notably, the company produces misoprostol (sold under the brand name of Invitec), a drug which is used to treat stomach ulcers but is also widely used in Indonesia as an illegal abortifacient (abortion-inducing substance).[1]

PT Kalbe Farma Tbk
Company typePublic
IDXKLBF
Industry
Founded10 September 1966; 57 years ago (1966-09-10)
HeadquartersJakarta, Indonesia
Area served
Worldwide
Key people
Vidjongtius (CEO)
Bernadette Ruth Irawati Setiady (President)
ProductsDrugs, energy drinks, milk, baby food, healthy drinks, herbal supplements and nutrition products
RevenueIncrease Rp 26.261 trillion (2021)
Increase Rp 3.208 trillion (2021)
Total assetsIncrease Rp 25.667 trillion (2021)
Total equityIncrease Rp 21.365 trillion (2021)
Number of employees
16,235 (2021)
Subsidiaries
  • Bintang Toedjoe
  • Kalbe Nutritionals
  • Kalbe Genexine Biologics
  • Innogene Kalbiotech
  • Bifarma Adiluhung
  • Kalbe International
  • Innolab Sains Internasional
  • Pharma Metric Labs
  • Saka Farma Laboratories
  • Dankos Farma
  • Hexpharm Jaya Laboratories
  • Hale International
  • Finusolprima Farma Internasional
  • Kalbe Milko Indonesia
  • Enseval Putera
  • Indogravure
  • Kalbe Morinaga
  • Kalbe Vision
Websitehttps://www.kalbe.co.id/

Company brands in healthcare and pharmaceutical segments include Promag, Mixagrip, Woods, Komix, Prenagen, Extra Joss and Fitbar.[citation needed]

Kalbe is the largest publicly listed pharmaceutical company in Southeast Asia with around US$5 billion in market capitalization and revenues of over Rp 15 trillion.

History

edit

Kalbe Farma was founded on September 10, 1966, by 6 siblings, K.L. Tjoen, Theresia H. Setiady, Khouw Lip Swan, Khouw Lip Boen (Also Known As: Dr. Boenyamin Setiawan), Maria Karmila, and F. Bing Aryanto. Kalbe Farma first began operations in a house garage that was owned by the founders.

In May 2020, Kalbe Farma signed a Memorandum of Understanding with South Korean pharmaceuticals company Genexine Inc. to develop a vaccine for the new corona virus or COVID-19.[2]

References

edit
  1. ^ Grafton-Green, Patrick (1 October 2017). "Anti-abortion MP Jacob Rees-Mogg admits profits from abortion pills". Evening Standard. Retrieved 25 March 2020.
  2. ^ "Kalbe Farma and South Korea's Genexine to Start Human Trial for Covid-19 Vaccine". Jakarta Globe. Retrieved 2020-09-06.
edit